Top NTRK Fusion Gene Positive Advanced Solid Tumor Companies

  1. Bayer

  2. Empire Genomics

  3. Roche

  4. NeoGenomics Laboratories

  5. OncoDNA S.A.

*Disclaimer: Top companies sorted in no particular order

NTRK Fusion Gene Positive Advanced Solid Tumor Market Major Players

NTRK Fusion Gene Positive Advanced Solid Tumor - Competitive Concentration

NTRK Fusion Gene Positive Advanced Solid Tumor Market Concentration

List of NTRK Fusion Gene Positive Advanced Solid Tumor Companies

  • Bayer

  • Eli Lilly and Company

  • Roche

  • Bristol-Myers Squibb

  • Blueprint Medicines Corp.

  • Novartis

  • Takeda Pharmaceutical Co.

  • Regeneron Pharmaceuticals

  • Pfizer

  • Guardant Health

  • NeoGenomics Laboratories

  • Foundation Medicine Inc.

  • Thermo Fisher Scientific

  • QIAGEN 

  • Illumina

  • Natera

  • Caris Life Sciences

  • Tempus Labs Inc.

  • OncoDNA S.A.

  • Empire Genomics LLC

  • LGC Clinical Diagnostics (SeraCare)

  • Fulgent Genetics Inc.

  • Exact Sciences Corp.

Get more insights on NTRK Fusion Gene Positive Advanced Solid Tumor industry from our comprehensive report